American Century Companies’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-391,051
Closed -$26.6M 2639
2022
Q3
$26.6M Buy
391,051
+13,189
+3% +$898K 0.02% 575
2022
Q2
$12.1M Buy
377,862
+25,527
+7% +$816K 0.01% 844
2022
Q1
$12.2M Sell
352,335
-1,410
-0.4% -$48.8K 0.01% 849
2021
Q4
$10.4M Buy
353,745
+11,720
+3% +$343K 0.01% 872
2021
Q3
$8.72M Sell
342,025
-331
-0.1% -$8.43K 0.01% 882
2021
Q2
$12M Buy
342,356
+134,684
+65% +$4.72M 0.01% 777
2021
Q1
$8.46M Buy
207,672
+79,887
+63% +$3.26M 0.01% 816
2020
Q4
$5.53M Buy
127,785
+42,459
+50% +$1.84M ﹤0.01% 864
2020
Q3
$4.71M Sell
85,326
-9,141
-10% -$504K ﹤0.01% 811
2020
Q2
$5.96M Sell
94,467
-6,367
-6% -$402K 0.01% 752
2020
Q1
$5.15M Sell
100,834
-5,199
-5% -$266K 0.01% 721
2019
Q4
$8.43M Buy
106,033
+40,715
+62% +$3.24M 0.01% 723
2019
Q3
$3.17M Buy
65,318
+3,846
+6% +$187K ﹤0.01% 891
2019
Q2
$3.23M Buy
61,472
+14,293
+30% +$752K ﹤0.01% 925
2019
Q1
$2.5M Sell
47,179
-8,762
-16% -$464K ﹤0.01% 962
2018
Q4
$2.3M Sell
55,941
-2,941
-5% -$121K ﹤0.01% 948
2018
Q3
$2.24M Sell
58,882
-419
-0.7% -$15.9K ﹤0.01% 1010
2018
Q2
$2.68M Buy
+59,301
New +$2.68M ﹤0.01% 968